journal article·2026-04

Carrier-free self-assembly of choline chloride-ammonium glycyrrhizinate hydrogel for myocardial infarction microenvironment regulation

Yi Hu, Wenhui Yang, Jiamian Zhan, Yue Ma, Pengqi Wang, Chunyi Pu, Linfang Zhong, Xiaozhong Qiu, Honghao Hou

Nano Today· Volume 68
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Cardiac Fibrosis and Remodeling · Tissue Engineering and Regenerative Medicine · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. BMAL1–HIF2A heterodimer modulates circadian variations of myocardial injury10.1038/s41586-025-08898-z ↗
2. Signaling pathways and targeted therapy for myocardial infarction10.1038/s41392-022-00925-z ↗
3. A Cardiac-Targeted Nanozyme Interrupts the Inflammation-Free Radical Cycle in Myocardial Infarction
4. Sweroside alleviates pressure overload-induced heart failure through targeting CaMKⅡδ to inhibit ROS-mediated NF-κB/NLRP3 in cardiomyocytes10.1016/j.redox.2024.103223 ↗
5. Mitochondrial quality control in cardiomyocytes: safeguarding the heart against disease and ageing10.1038/s41569-025-01142-1 ↗
6. Antiplatelet therapy in cardiovascular disease: Current status and future directions10.1111/bcp.15221 ↗
7. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction10.1056/NEJMoa2401479 ↗
8. Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction: An Overview of Long-term Randomized Controlled Trials10.1001/archinte.166.7.787 ↗
9. The role of antiplatelet therapy in the management of acute coronary syndromes10.1517/14740338.4.3.541 ↗
10. Reprogramming the myocardial infarction microenvironment with melanin-based composite nanomedicines in mice10.1038/s41467-024-50854-4 ↗
11. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair10.1038/s41392-020-00455-6 ↗
12. Single dose of intravenous miR199a-5p delivery targeting ischemic heart for long-term repair of myocardial infarction10.1038/s41467-024-49901-x ↗
13. Material assembly from collective action of shape-changing polymers10.1038/s41563-023-01761-4 ↗
14. Harnessing the Hofmeister Effect for Dynamic Self-Assembly of Supramolecular Hydrogels
15. Intravascularly infused extracellular matrix as a biomaterial for targeting and treating inflamed tissues10.1038/s41551-022-00964-5 ↗
16. A natural extracellular matrix hydrogel through selective nutrient restriction for hyperinflammatory starvation therapy10.1016/j.matt.2022.12.002 ↗
17. Physical strategies to engineer supramolecular composite hydrogels for advanced biomedical applications10.1016/j.pmatsci.2025.101428 ↗
18. Assembly delivery of bioactive matters: advances, challenges, and prospects
19. Eutectogels: recent advances and emerging biological applications
20. Molecular self-assembly strategy tuning a dry crosslinking protein patch for biocompatible and biodegradable haemostatic sealing10.1038/s41467-025-56726-9 ↗
21. Hydrogels for RNA delivery10.1038/s41563-023-01472-w ↗
22. A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors10.1021/jacs.4c00569 ↗
23. Exploring the self-assembled gel behaviour of litchi pulp arabinan enriched pectic polysaccharides by small and large amplitude oscillatory shear10.1016/j.foodhyd.2024.110974 ↗
24. Glucose Epimerization-Modulated Phytochemicals Constructing Carrier-Free Hydrogel for Regulation of Macrophage Phenotype to Promote Wound Healing
25. Nervous System Repair and Immunity: Chiral Effects of Biomimetic Self-Assembled Neuropeptide Hydrogels
26. Biotherapeutic-loaded injectable hydrogels as a synergistic strategy to support myocardial repair after myocardial infarction10.1016/j.jconrel.2021.05.023 ↗
27. Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics
28. A Strongly Robust Chitosan-Based Programmed Control Functional Hydrogel Improved Mitochondrial Function and Pro-Vascularization for Adaptive Repair of Myocardial Infarction
29. Exploring the molecular mechanisms of isoliquiritin extraction using choline chloride-citric acid deep eutectic solvents
30. Acetylcholine modulates the temporal dynamics of human theta oscillations during memory10.1038/s41467-023-41025-y ↗
31. Abomasal Infusion of Deuterium-Labeled Choline Confirms that Choline is a Methyl Donor in Gestating and Lactating Holstein Dairy Cattle10.1016/j.tjnut.2024.11.014 ↗
32. Effect of choline chloride in allergen-induced mouse model of airway inflammation10.1183/09031936.00019307 ↗
33. Effects of choline on the growth performance, antioxidant function and lipid metabolism in juvenile largemouth bass fed with high-fat diet
34. Glycyrrhiza, a commonly used medicinal herb: Review of species classification, pharmacology, active ingredient biosynthesis, and synthetic biology
35. Glycyrrhizic acid from licorice down-regulates inflammatory responses via blocking MAPK and PI3K/Akt-dependent NF-κB signalling pathways in TPA-induced skin inflammation10.1039/C8MD00288F ↗
36. Glycyrrhizin protects human melanocytes from H2O2‑induced oxidative damage via the Nrf2‑dependent induction of HO‑1
37. Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats10.3390/biom11040569 ↗
38. Cardioprotective Action of Glycyrrhizin on Diabetic Rats with Myocardial Remodeling
39. Enhancement of anti-inflammatory activity of glycyrrhizic acid by encapsulation in chitosan-katira gum nanoparticles10.1016/j.ejpb.2016.06.003 ↗
40. Glycyrrhizic acid as a multifunctional drug carrier – From physicochemical properties to biomedical applications: A modern insight on the ancient drug10.1016/j.ijpharm.2019.01.047 ↗
41. Identification and analysis of diagnostic markers related to lactate metabolism in myocardial infarction10.1016/j.prp.2025.156010 ↗
42. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources10.1038/nprot.2008.211 ↗
43. Computational protein–ligand docking and virtual drug screening with the AutoDock suite10.1038/nprot.2016.051 ↗
44. Junctophilin-2 Regulates Store-Operated Calcium Entry to Drive Cardiac Fibroblast Activation, Fibrotic Repair, and Angiogenesis After Myocardial Infarction10.1161/CIRCULATIONAHA.125.073937 ↗
45. Manipulation of surface potential distribution enhances osteogenesis by promoting pro-angiogenic macrophage polarization via activation of the PI3K-Akt signaling pathway
46. Kaempferol regulating macrophage foaming and atherosclerosis through Piezo1-mediated MAPK/NF-κB and Nrf2/HO-1 signaling pathway10.1016/j.jare.2024.11.016 ↗
47. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis10.1007/s10456-006-9055-8 ↗
48. Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective10.1016/j.medidd.2019.100009 ↗
49. The NF-kappaB family of transcription factors and its regulation10.1101/cshperspect.a000034 ↗
50. Rheology and sensory texture of biopolymer gels10.1016/j.cocis.2007.07.001 ↗
51. Mapping in situ the assembly and dynamics in aqueous supramolecular polymers10.1038/s41467-025-60138-0 ↗
52. Glycyrrhizic acid nanoparticles inhibit LPS-induced inflammatory mediators in 264.7 mouse macrophages compared with unprocessed glycyrrhizic acid
53. Choline chloride attenuates the allergic airway disease by inhibiting the lysophosphatidylcholine induced response in mouse model10.1016/j.crphar.2022.100109 ↗
54. Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice10.1007/s10753-015-0212-3 ↗
55. Sun, Q. 25-Hydroxyl-protopanaxatriol protects against H(2)O(2)-induced H9c2 cardiomyocytes injury via PI3K/Akt pathway and apoptotic protein down-regulation10.1016/j.biopha.2018.01.039 ↗
56. Cucurbitacin I Protects H9c2 Cardiomyoblasts against H(2)O(2)-induced oxidative stress via protection of mitochondrial dysfunction10.1155/2018/3016382 ↗
57. Overexpression of ryanodine receptor type 1 enhances mitochondrial fragmentation and Ca2+-induced ATP production in cardiac H9c2 myoblasts10.1152/ajpheart.00094.2013 ↗